Silco Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Silco Pharmaceuticals has a total shareholder equity of BDT2.4B and total debt of BDT0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are BDT2.8B and BDT467.2M respectively. Silco Pharmaceuticals's EBIT is BDT64.8M making its interest coverage ratio 693.6. It has cash and short-term investments of BDT66.0M.
Key information
0%
Debt to equity ratio
৳0
Debt
Interest coverage ratio | 693.6x |
Cash | ৳66.02m |
Equity | ৳2.35b |
Total liabilities | ৳467.19m |
Total assets | ৳2.82b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: SILCOPHL's short term assets (BDT1.1B) exceed its short term liabilities (BDT305.6M).
Long Term Liabilities: SILCOPHL's short term assets (BDT1.1B) exceed its long term liabilities (BDT161.6M).
Debt to Equity History and Analysis
Debt Level: SILCOPHL is debt free.
Reducing Debt: SILCOPHL had no debt 5 years ago.
Debt Coverage: SILCOPHL has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: SILCOPHL has no debt, therefore coverage of interest payments is not a concern.